Accelerated DMN-Targeted cTBS Improves Processing Speed Deficits in Schizophrenia

Key Points

• Processing speed improves with DMN-targeted cTBS, indicating potential benefits in cognitive functions.
• The primary metric observed is a notable reduction in cognitive impairment associated with schizophrenia.
• Personalized network targeted TMS was employed to assess cognitive function enhancement across affected individuals.
• Further research is needed to explore broader implications of TMS intervention on cognitive abilities.